Cynata Therapeutics Limited Receivables

Cynata Therapeutics Limited (CYYNF) currently reports a receivables of $70K as of June 2026. That compares with $100K in the prior-year period — down 32.7% year over year. Use the charts on this page to explore Cynata Therapeutics Limited's receivables history and peer comparisons.

Cynata Therapeutics Limited's receivables decreased from $100K to $70K — a 32.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cynata Therapeutics Limited reported $70K in receivables as of June 2026. That compares with $100K in the prior-year period — down 32.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $70K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cynata Therapeutics Limited, and consider following CYYNF for alerts when major investors trade the stock.

Cynata Therapeutics Limited is classified in the Healthcare sector. On receivables, it currently shows $70K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYYNF with unrelated industries.